Historical data shows that a consistent $500 monthly investment into Eledon Pharmaceuticals, Inc. (ELDN) starting in 2020 would have turned a total investment of $49K into $52K today. This represents a total return of 6.9% over the 6-year period, compounding through dividend reinvestment and market growth.
The Impact of Dividend Reinvestment (DRIP)
Eledon Pharmaceuticals, Inc. does not currently pay a notable dividend. For growth-focused stocks like ELDN, dollar cost averaging relies entirely on price appreciation. Over the 6-year period, the strategy successfully captured the stock's price movements, resulting in a final portfolio value of $52K without the need for dividend reinvestment.
ELDN vs. S&P 500 (SPY) Benchmark
When comparing this dollar cost averaging strategy against a broad market index,ELDN underperformed the S&P 500 ETF (SPY). The same $500 monthly contributions into SPY would have grown to $87K, compared to ELDN's $52K.